Avalo Therapeutics, Inc. (AVTX) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

16/25

Growth 4 Margin 3 Expansion 3 Platform 1 Financial 5

latest quarter score

Earnings Reports

16
AVTX Q3 2025: Portfolio Yield Climbs to 18.6% as Monroe Merger Sets Up Scale Leap
October 29, 2025
11
Horizon Technology Finance Corporation (HRZN) Q1 2025: $236M Backlog Boosts Portfolio Growth Amid Tariff Uncertainty
April 30, 2025
Horizon Technology Finance (AVTX) Q3 2024: Portfolio Grows 6% as Backlog Hits $190M, Pipeline Surges
October 30, 2024
Horizon Technology Finance (AVTX) Q2 2024: Portfolio Yield Climbs to 15.9% as Pipeline Rebuilds
July 31, 2024
Horizon Technology Finance (AVTX) Q1 2024: Backlog Drops $50M as Origination Pace Stays Cautious
May 01, 2024
Horizon Technology Finance (AVTX) Q4 2023: Portfolio Yield Climbs to 16.8% as Venture Market Stays Stressed
February 28, 2024

Browse all companies